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Abstract
Herbal medicines have recently been developed for the treatment of infectious diseases. The aim of this study was to 
investigate the therapeutic potential of Phoenix dactylifera fruit and kernel extracts against herpes simplex virus type 
1 (HSV-1) in an animal model. Five, 10, and 15% (w/w) concentrations of aqueous, ethanol, and acetone extracts of 
kernel and fruit of Phoenix dactylifera were used for the formulation of cream-based drugs for the treatment of HSV-
1-infected mice. The clinical improvement was evaluated using lesion scoring and histopathological assessments. 
Our results demonstrated that there is a potent antiviral activity associated with Phoenix dactylifera extract against 
HSV-1 infections. Treatment with cream containing 5% Phoenix dactylifera kernel ethanol extract was observed as 
the most efficient therapeutic potential to treat HSV-1-infected mice. Lesion scoring assessment and histopathological 
analysis showed more effective and faster antiviral activity of this treatment than other extracts and concentrations 
in comparison with the acyclovir, as the reference drug, for the treatment of HSV-1 infections. These findings sug-
gest that Phoenix dactylifera extract may be considered as an alternative to acyclovir and potential phototherapeutic 
against HSV-1 diseases; however, randomized clinical trial studies are strongly needed to ensure the quality, safety, 
and efficacy of the drug.
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Introduction
Herpes simplex virus (HSV), a member of the Herpesviridae 
family, cause a range of in human and animals which are 
partly life-threatening. Two types of HSV are common in 
human infections considered a significant public health con-
cern. The potential of primary infection was seen in persons 
who have not been infected by HSV types 1 or 2 previously 
(Birkmann and Zimmermann 2016). In maximum cases 
reported for this disease, clinically symptoms are ranged 
from mild pharyngitis to severe illnesses and occasionally 
death. HSV-1 is more common in children and frequently 
cause oral infections; however, most infected cases with 
genital herpes were caused by HSV-2. Pharyngitis, conjunc-
tivitis, skin vesicular eruption, and keratitis usually occurred 
in adolescents and adults by primary HSV-1 infection (Hu 
et al. 2016).
There are many antiviral drugs based on chemical and 
medicinal plants for the treatment of HSV infection. Acy-
clovir is the standard treatment as a typical chemical-based 
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